Marni Brisson Tierno
Impact in
-
- HER2/EGFR in Cancer Research
- Cancer Immunotherapy and Biomarkers
Papers in
-
- Cancer Genomics and Diagnostics 4
-
- Prostate Cancer Treatment and Research 3
- Co-authors
- John S. Lazo (3 shared papers)Sunita N. Shinde (2 shared papers)Caleb Foster (2 shared papers)Paul A. Johnston (2 shared papers)Tong Ying Shun (2 shared papers)Peter Wipf (2 shared papers)Norman Wolmark (1 shared paper)Marc Buyse (1 shared paper)
- Journals
- Journal of Clinical Oncology (2 papers)The Prostate (1 paper)Frontiers in Oncology (1 paper)Assay and Drug Development Technologies (1 paper)Nature Protocols (1 paper)
- Partner nations
- United StatesSwitzerlandBelgium
In The Last Decade
Marni Brisson Tierno
13 papers receiving 274 citations
Peers
Comparison fields: 5 of 48
- Toxicology 14
- Oncology 93
- Cancer Research 47
- Pulmonary and Respiratory Medicine 60
- Immunology 38
Countries citing papers authored by Marni Brisson Tierno
This map shows the geographic impact of Marni Brisson Tierno's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marni Brisson Tierno with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marni Brisson Tierno more than expected).
Fields of papers citing papers by Marni Brisson Tierno
This network shows the impact of papers produced by Marni Brisson Tierno. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marni Brisson Tierno. The network helps show where Marni Brisson Tierno may publish in the future.
Co-authors
The 25 scholars most cited alongside Marni Brisson Tierno, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2007 | 55 | |
| 2 | 2013 | 49 | |
| 3 | 2022 | 49 | |
| 4 | 2009 | 33 | |
| 5 | 2008 | 32 | |
| 6 | 2018 | 22 | |
| 7 | 2022 | 16 | |
| 8 | 2022 | 13 | |
| 9 | 2022 | 4 | |
| 10 | 2024 | 2 | |
| 11 | 2025 | 2 | |
| 12 | 2025 | 1 | |
| 13 | 2024 | 1 |
About Marni Brisson Tierno
Marni Brisson Tierno is a scholar working on Cancer Research, Pulmonary and Respiratory Medicine, Oncology, Molecular Biology and Organic Chemistry, having authored 13 papers that have together received 279 indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (4 papers), Prostate Cancer Treatment and Research (3 papers), Protein Tyrosine Phosphatases (2 papers), Biochemical and Molecular Research (2 papers), PARP inhibition in cancer therapy (2 papers), Pediatric Hepatobiliary Diseases and Treatments (1 paper), BRCA gene mutations in cancer (1 paper) and Liver physiology and pathology (1 paper). The work is most often cited by research in Toxicology (14 citations), Oncology (93 citations), Cancer Research (47 citations), Pulmonary and Respiratory Medicine (60 citations) and Immunology (38 citations). Marni Brisson Tierno has collaborated with scholars based in United States, Switzerland and Belgium. Frequent co-authors include John S. Lazo, Sunita N. Shinde, Caleb Foster, Paul A. Johnston, Tong Ying Shun, Peter Wipf, Norman Wolmark, Marc Buyse, Samuel A. Jacobs and Steven Limentani. Their work appears in journals such as Journal of Clinical Oncology, The Prostate, Frontiers in Oncology, Assay and Drug Development Technologies and Nature Protocols.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.